PA
TASK icon

PharVision Advisers’s TaskUs TASK Stock Holding History

PharVision Advisers’s Portfolio TASK Stock Details TASK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,193
Closed -$262K – 586
2025
Q4 		$262K Buy
+22,193
New +$284K 0.13% 363
2025
Q2 		– Sell
-17,245
Closed -$235K – 425
2025
Q1 		$235K Buy
+17,245
New +$259K 0.33% 149

Other funds holding TASK

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MVP
Medina Value Partners Los Angeles, California $477M AUM 25.52% 1-Year Est. Return
DI
Dalton Investments Las Vegas, Nevada $103M AUM 3.77% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's TASK Position: Q1 2026 in Review

PharVision Advisers sold out of TaskUs (TASK) in Q1 2026, closing a stake of 22,193 shares — an estimated $262K sold.

PharVision Advisers first reported a position in TASK in Q1 2025 and held it in 2 quarters. The position peaked at $262K in Q4 2025. 108 funds tracked by Wall St. Rank hold TASK as of Q1 2026.

  • PharVision Advisers reported no remaining TaskUs position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 22,193 TaskUs shares in Q1 2026, an estimated $262K.
  • PharVision Advisers first reported a position in TaskUs in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's TaskUs position peaked at $262K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held TaskUs as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.